Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03024996 |
|---|---|
| Brief Title: | A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy (IMmotion010) |
| First Submitted : | January 17, 2017 |
| First Submitted that Met QC Criteria : | January 17, 2017 |
| First Posted : | January 19, 2017 (Estimate) |
| Results First Submitted : | April 18, 2023 |
| Results First Submitted that Met QC Criteria : | July 14, 2023 |
| Results First Posted : | August 3, 2023 |
| Last Update Submitted that Met QC Criteria : | July 14, 2023 |
| Last Update Posted : | August 3, 2023 |